Using a large cohort over a period of 38 years, the researchers assessed thrombocytopenia and other clinical variables as predictors of outcomes in patients with antiphospholipid syndrome.
The rate of alopecia areata (AA) in patients with systemic lupus erythematosus (SLE) determined via biopsy was assessed, and the rate of scalp biopsy in determination of nonscarring alopecia in patients with SLE was evaluated.
In a multicenter study, researchers evaluated the characteristics of hematologic involvement and assessed the association in patients with pediatric systemic lupus erythematosus.
Researchers highlighted the importance of a consensus to address inconsistencies in the metrics and definitions used for cognitive impairment assessment in systemic lupus erythematosus.
An overview of a review paper by Ibrahim Almaghlouth and colleagues highlighting the principles of immunoglobulin measurements and the primary and secondary causes of low immunoglobulin levels in patients with systemic lupus erythematosus.
Researchers evaluated the association between hydroxychloroquine and risk for incident atrial fibrillation in patients with systemic lupus erythematosus.
In this review, the author discusses the use of autoantibodies as biomarkers for the differential diagnosis of neuropsychiatric systemic lupus erythematosus.
Researchers assessed the presence of SARS-CoV-2 IgG antibodies in patients with SLE with or without previous COVID-19-related symptoms or confirmed infection with SARS-CoV-2.
Researchers aimed to study the correlation between irreversible organ damage and quality of life in systemic lupus erythematosus, and to identify the type of organ damage that is negatively correlated with QOL.
Investigators assessed the role of cell-mediated immunity in the development of cytomegalovirus infection in patients with systemic lupus erythematosus undergoing treatment with immunosuppressants.
